There is a paucity of head-to-head comparisons of the efficacy and harms of pharmacological treatments for systemic sclerosis-related interstitial lung disease (SSc-ILD).
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis / Erre, G.L., Sebastiani, M., Fenu, M.A., Zinellu, A., Floris, A., Cavagna, L., Renzoni, E., Manfredi, A., Passiu, G., Woodman, R.J., Mangoni, A.A.. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 9:8(2020), p. 2560. [10.3390/jcm9082560]
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
Erre, Gian Luca
;Fenu, Maria Antonietta;Zinellu, Angelo;Passiu, Giuseppe;Mangoni, Arduino Aleksander
2020-01-01
Abstract
There is a paucity of head-to-head comparisons of the efficacy and harms of pharmacological treatments for systemic sclerosis-related interstitial lung disease (SSc-ILD).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
